Literature DB >> 6470967

Determination of acetazolamide in biological fluids by reverse-phase high-performance liquid chromatography.

D J Chapron, L B White.   

Abstract

A high-performance liquid chromatographic method for the determination of acetazolamide in whole blood, plasma, and urine was developed. Samples of biological fluids containing various concentrations of acetazolamide were spiked with the internal standard, sulfadiazine. Samples were then mixed with a 50% ammonium sulfamate solution. Whole blood samples were heated for 25 s in boiling water. All samples were extracted with ethyl acetate; a phosphate buffer (pH 8.0) was used to wash the extracts. Acetazolamide was back-extracted into a glycine buffer (pH 10.0), which was then washed with ether. Separation of acetazolamide and internal standard from other biological constituents was achieved on a 10-micron C18 reverse-phase column using an acetonitrile-methanol-acetate buffer (pH 4.0). The eluant was monitored at 254 nm. All calibration curves were linear, and the results from reproducibility studies were excellent. Application of the method to human pharmacokinetic studies was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470967     DOI: 10.1002/jps.2600730732

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans.

Authors:  K R Sweeney; D J Chapron; E J Antal; P A Kramer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

2.  Influence of advanced age on the disposition of acetazolamide.

Authors:  D J Chapron; K R Sweeney; P U Feig; P A Kramer
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

3.  Validated Stability indicating Spectrophotometric Method for the Determination of Acetazolamide in Dosage Forms through Complex Formation with Palladium (II).

Authors:  M I Walash; A El-Brashy; N El-Enany; M E K Wahba
Journal:  Int J Biomed Sci       Date:  2010-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.